Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 3/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.57 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.44 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29737473 | 1.00 | HSD17B10 (1.00) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL699045 | 0.90 | HSD17B10 (0.81) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL3814907 | 0.89 | HSD17B10 (0.79) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL10079022 | 0.89 | HSD17B10 (0.79) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL7262126 | 0.87 | HSD17B10 (0.76) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL30387687 | 0.87 | HSD17B10 (0.76) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL30013531 | 0.87 | HSD17B10 (0.76) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL2788717 | 0.86 | HSD17B10 (0.76) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL20488085 | 0.85 | HSD17B10 (0.73) | HSD17B10SMN1; SMN2CA12CA1CA2 | |
| Biphenyl SCHEMBL976757 | 0.84 | HSD17B10 (0.72) | HSD17B10ALOX5ALDH1A1FOLH1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3142777-B1 | COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITROUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-10-24 | — | — | EP | disclosed |
| EP-3092057-B1 | TREATMENT OF AQUEOUS MIXTURES CONTAINING ANIONIC SURFACTANTS USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3092056-B1 | DESALINATION OF AQUEOUS MIXTURE CONTAINING NANO-SIZED PARTICLES USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-3077088-B1 | METHOD FOR FORMING A COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITRIOUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-12-27 | — | — | EP | disclosed |
| US-9808769-B2 | Composite polyamide membrane post treated with nitrious acid | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-11-07 | — | — | US | disclosed |
| EP-3142777-A1 | COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITROUS ACID | Dow Global Technologies LLC (US) | 2017-03-22 | — | — | EP | disclosed |
| US-20170050152-A1 | COMPOSITE POLYAMIDE MEMBRANE POST TREATED WITH NITROUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-02-23 | — | — | US | disclosed |
| EP-3092057-A1 | TREATMENT OF AQUEOUS MIXTURES CONTAINING ANIONIC SURFACTANTS USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | Dow Global Technologies LLC (US) | 2016-11-16 | — | — | EP | disclosed |
| EP-3092056-A1 | DESALINATION OF AQUEOUS MIXTURE CONTAINING NANO-SIZED PARTICLES USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | Dow Global Technologies LLC (US) | 2016-11-16 | — | — | EP | disclosed |
| US-20160303516-A1 | DESALINATION OF AQUEOUS MIXTURE CONTAINING NANO-SIZED PARTICLES USING FOULING RESISTANT REVERSE OSMOSIS MEMBRANE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-10-20 | — | — | US | disclosed |
| US-20150065542-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2015-03-05 | — | — | US | disclosed |
| US-20140364617-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2014-12-11 | — | — | US | disclosed |
| US-20140364617-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2014-12-11 | — | — | US | disclosed |
| WO-2012083053-A2 | ANTI-VIRAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2012-06-21 | — | — | WO | disclosed |
| EP-0968310-B1 | NOVEL PHENOL CONDENSATION PRODUCTS | BAYER AG (DE) | 2002-06-26 | — | — | EP | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-4927903-A | ESTERIFICATION OF POLYCARBONATE | BAYER AKTIENGESELLSCHAFT (DE) | 1990-05-22 | — | — | US | disclosed |
| EP-0127842-B1 | DIPHENOL MONOESTERS OF CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR USE IN THE PREPARATION OF POLYESTER CARBONATES, POLYESTER CARBONATES OBTAINED ACCORDING TO THE INVENTION AND FLAME-RETARDANT MOULDING COMPOUNDS CONTAINING THESE POLYESTER CARBONATES | BAYER AG (DE) | 1986-07-02 | — | — | EP | disclosed |
| EP-0127842-A1 | Diphenol monoesters of carboxylic acids, process for their preparation, their use in the preparation of polyester carbonates, polyester carbonates obtained according to the invention and flame-retardant moulding compounds containing these polyester carbonates | BAYER AG (DE) | 1984-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364617-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, EIF2AK2, MAVS | HSD17B10 1774/4885SMN1; SMN2 3721/4885CA12 3463/4885 |
| US-20150065542-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, EIF2AK2, MAVS | HSD17B10 1774/4885SMN1; SMN2 3721/4885CA12 3463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.